Why the study?
The study was conducted to investigate the impact of postoperative morbidity on mid-term quality of life and patient-reported outcome parameters after colorectal surgery for colorectal carcinoma.
Does postoperative morbidity worsen mid-term quality of life in adult patients after colorectal surgery for colorectal carcinoma?
Does postoperative morbidity worsen mid-term quality of life in adult patients after colorectal surgery for colorectal carcinoma?
Postoperative morbidity does not appear to significantly impair mid-term quality of life at one year following R0 resection for colorectal carcinoma.
Answers are grounded in this paper and cite their sources.
Postoperative morbidity was not linked to worse mid-term QoL after colorectal cancer resection; leaves open effects on other PROs or subgroups.
Objectives: The aim of the present study was to investigate the impact of postoperative morbidity on mid-term quality of life and patient-related outcome (PRO) parameters after colorectal surgery for colorectal carcinoma. Methods: Quality of life and perioperative data were prospectively collected from 99 adult patients treated for colorectal carcinoma—56 patients with colonic carcinoma and 43 with rectal carcinoma, all of whom underwent R0 colorectal resection, at the University Hospital Erlangen between 2018 and 2021. Quality of life data (EQL C29 and C30) were assessed before the start of treatment and one year after. Patients were grouped based on the presence or absence of postoperative morbidity, and their quality of life was compared between the two groups. Results: In the colonic carcinoma cohort, global quality of life and emotional functioning showed significant improvement from pre-treatment to the one-year follow-up (63 vs. 72, p = 0.012 and 63 vs. 76, p = 0.009, respectively). Among the symptom scales, five items improved, while two worsened. Patients who experienced postoperative morbidity (32% in the colonic carcinoma group) did not exhibit worse outcomes in functioning or symptom scales compared to those without morbidity (4 items improved and 1 worsened in the morbidity group vs. 3 improved and 1 worsened in the no-morbidity group). The rectal carcinoma cohort demonstrated a decline in quality of life from pre-treatment to the one-year follow-up. Two functioning scales worsened significantly (physical function: 89 vs. 83, p < 0.001; role function: 81 vs. 68, p = 0.009), and twelve symptom scales showed deterioration, with only two symptom scales improving. Postoperative morbidity (33% in the rectal carcinoma group) did not result in more pronounced impairments compared to those without morbidity. The morbidity group experienced 2 worsened and 0 improved items, while the no-morbidity group had 10 worsened and 1 improved item. Conclusions: Postoperative morbidity was not significantly associated with a worse quality of life at one-year follow-up after treatment of colorectal carcinomas, including colorectal resections, compared to patients who did not develop postoperative morbidity.
No takes yet. Share an insight, caveat, or question.
Brunner et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: